PAS
ABMD

Park Avenue Securities’s Abiomed Inc ABMD Stock Holding History

Park Avenue Securities’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,134
Closed -$1.02M – 1226
2022
Q3 		$1.02M Sell
4,134
-111
-3% -$30K 0.02% 449
2022
Q2 		$1.05M Buy
4,245
+460
+12% +$124K 0.02% 442
2022
Q1 		$1.25M Buy
3,785
+3,127
+475% +$963K 0.02% 403
2021
Q4 		$236K Buy
658
+34
+5% +$11.5K ﹤0.01% 1005
2021
Q3 		$203K Buy
+624
New +$211K ﹤0.01% 995

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Park Avenue Securities's ABMD Position: Q4 2022 in Review

Park Avenue Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,134 shares — an estimated $1.02M sold.

Park Avenue Securities first reported a position in ABMD in Q3 2021 and held it in 5 quarters. The position peaked at $1.25M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Park Avenue Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Park Avenue Securities sold 4,134 Abiomed Inc shares in Q4 2022, an estimated $1.02M.
  • Park Avenue Securities first reported a position in Abiomed Inc in Q3 2021 and held it in 5 quarters.
  • Park Avenue Securities's Abiomed Inc position peaked at $1.25M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Park Avenue Securities's 13F filing for Q4 2022, filed 24 Jan 2023.